Venus Remedies Ltd

Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 15 Dec 2025 as the stock hit its lower circuit limit, reflecting intense selling pressure and a significant intraday loss of 5.0%. The stock’s performance notably underperformed its sector and the broader market, signalling heightened investor caution and unfilled supply at lower price levels.

Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.839 today, underscoring a remarkable trajectory of growth and resilience in a competitive market environment.

Venus Remedies has reached a new 52-week high of Rs.839, reflecting a strong rally in the Pharmaceuticals & Biotechnology sector. This milestone highlights the stock’s sustained momentum, supported by robust financial performance and favourable market conditions.

Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.825 today, underscoring a notable phase of momentum in the stock’s performance. This milestone reflects a sustained upward trend supported by robust financial metrics and market dynamics.

Venus Remedies Ltd has delivered remarkable returns over multiple time horizons, firmly establishing itself as a multibagger stock within the Pharmaceuticals & Biotechnology sector. The company’s performance has significantly outpaced benchmark indices, reflecting robust financial growth and operational strength.

Venus Remedies Ltd witnessed a sharp decline on 9 Dec 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical company’s shares closed near the day’s low, reflecting a maximum daily loss of 4.96%, signalling panic selling and a significant imbalance between supply and demand.

Venus Remedies Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, faced intense selling pressure on 4 December 2025, resulting in the stock hitting its lower circuit limit. The share price closed at ₹770.0, marking a maximum daily loss and signalling a wave of panic selling that left a significant portion of supply unfilled in the market.

Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.808.5 today, underscoring a remarkable rally in its stock price. This milestone reflects sustained momentum driven by strong financial performance and favourable market conditions.

Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.808.5 today, underscoring a remarkable rally that has captured market attention. This milestone reflects sustained momentum supported by strong financial performance and favourable market conditions.

Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.808.5 today, underscoring a remarkable rally that reflects sustained momentum and strong market positioning over the past year.

Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.808.5 today, marking a significant milestone in its market journey. This peak reflects the company’s sustained performance and notable gains over recent periods.

Venus Remedies has experienced a notable revision in its market evaluation, reflecting a more favourable analytical perspective driven by robust financial trends and technical signals. This shift highlights the company’s strengthening position within the Pharmaceuticals & Biotechnology sector, supported by impressive profit growth and attractive valuation metrics.

Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.799.4 today, reflecting a strong rally and sustained momentum over recent sessions. This milestone underscores the stock’s robust performance amid a mixed market backdrop.

Venus Remedies has reached a new 52-week high of Rs.799.4, reflecting a strong upward momentum in the Pharmaceuticals & Biotechnology sector. This milestone underscores the stock's robust performance amid a mixed market environment, with the company demonstrating sustained gains over recent sessions.

Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.799.4 today, reflecting a strong momentum in its stock performance amid a mixed market environment.

Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs. 783.6 today, underscoring a significant milestone in its market journey. The stock’s performance has been notable across multiple timeframes, reflecting sustained momentum and robust financial metrics.

Venus Remedies Ltd witnessed robust buying interest on 2 Dec 2025, hitting its upper circuit limit of 5.0% to close at a new 52-week and all-time high of ₹763.4. The pharmaceutical and biotechnology company outperformed its sector and the broader market, reflecting heightened investor enthusiasm and a surge in demand that led to a regulatory trading freeze.

Venus Remedies Ltd has surged to a new 52-week and all-time high of Rs. 761.65, propelled by extraordinary buying interest that has left the stock with only buy orders in the queue. This rare market phenomenon signals a potential multi-day upper circuit scenario, underscoring the stock’s strong momentum in the Pharmaceuticals & Biotechnology sector.

Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.761.65 today, underscoring a notable rally and sustained momentum in its stock performance.